Sera Prognostics, Inc.
SERA- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001534969
In the last 90 days, Sera Prognostics, Inc. insiders filed 0 open-market purchases and 5 sales; 47 institutions reported holding it in 13F filings for Q2 2026, worth $31.0M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Sera Prognostics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 37 | 45 | +8 |
| Shares | 9.28M | 9.66M | +384.5K (+4.1%) |
| Value | $63.8M | $36.6M | −$27.2M (−42.6%) |
New holders (10)
Institutions that held Sera Prognostics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ensign Peak Advisors, Inc | 18,108 | $69.0K | 0.00% |
| Charles Schwab Investment Management Inc | 17,744 | $68.0K | 0.00% |
| Aspiriant, LLC | 16,472 | $62.0K | 0.00% |
| Goldman Sachs Group Inc | 10,819 | $41.0K | 0.00% |
| Frontier Wealth Management LLC | 11,900 | $30.0K | 0.00% |
| Barclays PLC | 1,283 | $5.00K | 0.00% |
| Amalgamated Bank | 699 | $3.00K | 0.00% |
| Amalgamated Financial Corp. | 699 | $3.00K | 0.00% |
| FMR LLC | 118 | $0 | 0.00% |
| Ellevest, Inc. | 11 | $0 | 0.00% |
Sold out (2)
Institutions that held Sera Prognostics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Citadel Advisors LLC | 21,872 | $151.0K |
| Wells Fargo & Company | 39 | $0 |